Regulus Therapeutics (RGLS) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RGLS Regulus Therapeutics

Watchlist

1.6400
+0.0600+3.80%

Trading Oct 7 14:01 ET

107.36MMarket Cap-1366P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences
newsfilter.ioAug 28 08:00 ET
Buy Rating Reaffirmed for Regulus Therapeutics Amidst Promising Clinical Data and Progress Towards Pivotal Trial
TipRanksAug 9 08:10 ET · Ratings
Regulus Therapeutics Q2 EPS $(0.17) Misses $(0.13) Estimate
BenzingaAug 8 17:34 ET
Express News | Regulus Therapeutics Inc: Ended Q2 2024 With Cash, Cash Equivalents, and Investments of $95.9 Mln; Cash Runway Into H1 2026
ReutersAug 8 16:43 ET
Regulus Therapeutics | 10-Q: Q2 2024 Earnings Report
SECAug 8 16:30 ET · Announcements
Express News | Regulus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Updates
ReutersAug 8 16:05 ET

Comments

Dragana

Sep 12 21:46

$Regulus Therapeutics (RGLS.US)$ is ready Almost there.🙌

Ultratech

Sep 12 20:46

$Regulus Therapeutics (RGLS.US)$
Vanguard loaded

Trytosaveabit

Aug 1 17:56

NFA! Because you asked!

So ive been asked by quite a few people that are newer traders! And because of being where we all have been. They are learning charts and where to enter and exit on momentum / day trades. But having a bit of trouble. Again as we all did and at times still do. Most know that because i cant know others risk tolerance. Or the type of trade they are doing? That i do not give buy / sell advice. But i was asked could i give some swing trade ideas, so they could have a chance to ...

Newbie93

Jun 28 10:05

$Regulus Therapeutics (RGLS.US)$ probably going to below 1$

Stock Region

Jun 25 18:14

Therapeutics Company Reports Positive Topline Data From Major Clinical Trial

Positive Topline Data from Regulus Therapeutics' Phase 1b MAD Clinical Trial of RGLS8429 for ADPKD.
Regulus Therapeutics Inc., a biopharmaceutical company listed on Nasdaq under the ticker symbol RGLS, has recently announced positive topline results from the third cohort of patients in its Phase 1b Multiple-Ascending Dose (MAD) clinical trial of RGLS8429. This investigational drug is being developed for the treatment of ...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

RGLS Regulus Therapeutics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target